Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted therapy for osteosarcoma: a review
Shizhe Li, He Zhang, Jinxin Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6785-6797
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Doxorubicin loaded octacalcium phosphate particles as controlled release drug delivery systems: Physico-chemical characterization, in vitro drug release and evaluation of cell death pathway
Ilijana Kovrlija, Elżbieta Pańczyszyn, Öznur Demir, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123932-123932
Open Access | Times Cited: 12
FSP1 is a predictive biomarker of osteosarcoma cells’ susceptibility to ferroptotic cell death and a potential therapeutic target
Elżbieta Pańczyszyn, Valentina Saverio, Romina Monzani, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Endosomal escape in magnetic nanostructures: Recent advances and future perspectives
Shubhangi D. Shirsat, Prajkta V. Londhe, Ashwini P. Gaikwad, et al.
Materials Today Advances (2024) Vol. 22, pp. 100484-100484
Open Access | Times Cited: 9
A 10-year bibliometric analysis in the field of osteosarcoma treatment from 2014 to 2023
Yiguo Shen, Xiao-Bo Shao, Jiansong Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
Bikesh K. Nirala, Taku Yamamichi, Jason T. Yustein
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11367-11367
Open Access | Times Cited: 17
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment
Yujing Guan, Wei Zhang, Yuling Mao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Mg alloys with antitumor and anticorrosion properties for orthopedic oncology: A review from mechanisms to application strategies
Zhensheng Lin, Yuhe Wei, Huazhe Yang
APL Bioengineering (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 5
Advancements in nanoparticles-based therapeutic approaches for osteosarcoma: Insights from catechins-modified selenium-doped hydroxyapatite: A review
Tao Degang, Wei Xu, Shen Jianying, et al.
Medicine (2025) Vol. 104, Iss. 7, pp. e41489-e41489
Open Access
Clinicopathological correlations and prognostic insights in osteosarcoma: a retrospective analysis
Ştefan Adrian Niculescu, Alexandru Florian Grecu, Alex Emilian Stepan, et al.
Romanian Journal of Morphology and Embryology (2025) Vol. 65, Iss. 4, pp. 723-736
Open Access
MEK5–ERK5 pathway mediates mitophagy by regulating Nur77 to promote tumorigenesis of osteosarcoma cells
Jianshu Wang, Jinxu Xue, Baijing Ma, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
CCCTC-binding factor regulates splicing factor proline and glutamine-rich to promote malignant growth of osteosarcoma
Dapeng Li, Yang Yang, Zhengyu Yin, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1495-1509
Closed Access
Bibliometric analysis of autophagy in the diagnosis and treatment of osteosarcoma: a bibliometric analysis (2007–2023)
Min Zhu, Wei Xiang, Zhoujun Zhu, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Self-assembled chitosan-sodium usnate drug delivery nanosystems: Synthesis, characterization, stability studies, in vitro cytotoxicity and in vivo biocompatibility against 143 B cells
Benedetta Brugnoli, Alessia Mariano, Beatrice Simonis, et al.
Carbohydrate Polymer Technologies and Applications (2023) Vol. 6, pp. 100373-100373
Open Access | Times Cited: 11
Current status and future challenges of CAR-T cell therapy for osteosarcoma
Shizhe Li, He Zhang, Guanning Shang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics
Shivkanya Fuloria, Geeta Yadav, Soumya V. Menon, et al.
Pathology - Research and Practice (2024) Vol. 259, pp. 155346-155346
Closed Access | Times Cited: 4
Therapeutic Potential of Flavonoids in Osteosarcoma: Molecular Mechanisms and Clinical Implications
Zhenhai Cai, Jieen Pan, Xiaojun He, et al.
Pharmacognosy Magazine (2025)
Closed Access
Anti-osteosarcoma activity of Corynoline via Src/JNK signaling-mediated cell cycle arrest and mitochondrial apoptosis
Mufeng Li, Jianhang Jiao, Weibo Jiang, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114126-114126
Closed Access
Gelatin-based biomaterials as a delivery strategy for osteosarcoma treatment
Qifan Yang, X. Chen, Jing Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The resection of extraosseous osteosarcoma was accompanied by the occurrence of pulmonary metastasis and distal metastasis at the primary site: a case report
Han Liu, Leilei Tian, Jianhua Mu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo
Xuwen Chen, Zhengli Luo, Zongjing Hu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116082-116082
Closed Access | Times Cited: 3
Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis
Jiamin Jin, Jiacheng Cong, Shangbo Lei, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110422-110422
Closed Access | Times Cited: 7
Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma
Shuai Han, Qinghe Wang, Mingquan Shen, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27630-e27630
Open Access | Times Cited: 2
Epidemiology and nomogram of pediatric and young adulthood osteosarcoma patients with synchronous lung metastasis: A SEER analysis
Tao Liu, Lin Cui, Zongyun He, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288492-e0288492
Open Access | Times Cited: 5
Loss of NSUN6 inhibits osteosarcoma progression by downregulating EEF1A2 expression and activation of Akt/mTOR signaling pathway via m5C methylation
Sang Hu, Min Yang, Kang-Wen Xiao, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 4
Engineered nanomaterials enhance drug delivery strategies for the treatment of osteosarcoma
Haorui Zhang, Ping Luo, Xiaojun Huang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top